Searched for
DRL NEWS UPDATE
Dr Reddy's Laboratories jumps into the fray for Biogen's biosimilarsDr Reddy's Laboratories (DRL) and Intas Pharmaceuticals, both Indian companies, are reportedly in the race to acquire the biosimilar produc...
Dr Reddy's Labs Q4 Results: PAT sees nine-fold jump to Rs 960 crore, dividend declared at Rs 40/shareIndian pharmaceutical major Dr Reddy's Laboratories reports a whopping 890% YoY growth in net profit. Revenue from operations stood at Rs 5...
Dr Reddy’s Q2 results: Consolidated PAT rises 30% YoY, beats estimateThe drugmaker reported an 18 per cent on-year rise in consolidated revenues to Rs. 5,763 crore for the reported quarter, which also beat St...
TRACK SENSEX, NIFTY LIVE: Who moved my market todayIf you are reading this, chances are the Sensex and the Nifty are part of your daily life, and actions on Dalal Street can make or mar your...
TRACK SENSEX, NIFTY LIVE: Who moved my market todayIf you are reading this, chances are the Sensex and the Nifty are part of your daily life, and actions on Dalal Street can make or mar your...
TRACK SENSEX, NIFTY LIVE: Who moved my market todayIf you are reading this, chances are Sensex and Nifty are part of your daily life, and actions on Dalal Street can make or mar your day. He...
Who moved my market on MondayIn this space, ETMarkets.com tracks the elite 30 from the Sensex pack, 50 from the nimble Nifty LIVE, the newsmakers and top market movers ...
USFDA becoming dreaded word in Dalal Street; pharma companies need to keep Street in the loopThe stock of drug major Dr Reddy’s Labs (DRL) crashed 22% in the last three days, swiftly eroding the gains made over the last five months.
- Many deals didn’t meet our investment criteria: Chrys Capital
In conversation with ET , Mr Kaul, managing director, ChrysCapital discusses the changing landscape of Indian pharma and the firm’s investm...
- Blogs provide window to pharmaceutical industry in India
Discussions are posted by bloggers on ayurveda, biogenerics, combination drugs, patents, HIV as well as individual pharma cos. Scripting In...